These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3108634)

  • 21. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
    Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
    Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
    Bird HA
    Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869
    [No Abstract]   [Full Text] [Related]  

  • 23. A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.
    Aylward M; Maddock J; Wheeldon R; Parker RJ
    Rheumatol Rehabil; 1975 May; 14(2):101-14. PubMed ID: 238274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Copper metabolism in rheumatoid arthritis and influence of D-penicillamine treatment].
    Crouzet J; Nafziger J; Guillien P; Camus JP; Lièvre JA
    Rev Rhum Mal Osteoartic; 1973; 40(7):485-9. PubMed ID: 4756424
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis.
    Walters MT; Stevenson FK; Goswami R; Smith JL; Cawley MI
    Ann Rheum Dis; 1989 Nov; 48(11):905-11. PubMed ID: 2512862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.
    Hurst NP; Bell AL; Nuki G
    Ann Rheum Dis; 1986 Jan; 45(1):37-43. PubMed ID: 3006610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
    Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship between the complex of immunoglobulin A and alpha-1-antitrypsin, its constituent components and the acute-phase response as measured by C-reactive protein in rheumatoid arthritis treated with gold or D-penicillamine.
    Dawes PT; Jackson R; Shadforth MF; Lewin IV; Stanworth DR
    Br J Rheumatol; 1987 Oct; 26(5):351-3. PubMed ID: 2444302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ankylosing spondylitis and rheumatoid arthritis in a patient with Paget's disease. Differential effects of indomethacin, D-penicillamine, or gold sodium thiomalate in the respective arthritides.
    Alarcón-Segovia D; Martínez-Cordero E
    Arch Intern Med; 1985 Oct; 145(10):1915-7. PubMed ID: 3929708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 31. Rheumatoid arthritis V: therapy with remission-inducing agents.
    Gaines LM
    Md State Med J; 1982 Sep; 31(9):49-50. PubMed ID: 6815385
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of antirheumatic drugs on renal function and eicosanoid excretion.
    Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
    Scand J Rheumatol Suppl; 1987; 67():17. PubMed ID: 3133759
    [No Abstract]   [Full Text] [Related]  

  • 33. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E; Kåss E
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of the disease-modifying anti-arthritic thiol agents D-penicillamine and sodium aurothiomalate: restoration of cellular free thiols and sequestration of reactive aldehydes.
    Wood PL; Khan MA; Moskal JR
    Eur J Pharmacol; 2008 Feb; 580(1-2):48-54. PubMed ID: 18022616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigation of the action of disease modifying antirheumatic drugs on the rheumatoid synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold or penicillamine therapy.
    Walters MT; Smith JL; Moore K; Evans PR; Cawley MI
    Ann Rheum Dis; 1987 Jan; 46(1):7-16. PubMed ID: 3101623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does second-line therapy affect the radiological progression of rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1984 Feb; 43(1):18-23. PubMed ID: 6421253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
    Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that D-penicillamine alters the course of rheumatoid arthritis.
    Gibson T; Huskisson EC; Wojtulewski JA; Scott PJ; Balme HW; Burry HC; Grahame R; Hart FD
    Rheumatol Rehabil; 1976 Aug; 15(3):211-5. PubMed ID: 823633
    [No Abstract]   [Full Text] [Related]  

  • 40. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
    Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
    Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.